CRP and type 2 diabetes mellitus: In a follow-up study conducted, one year later, by the same group on patients with type 2 diabetes (26 men and 44 postmenopausal women) who had elevated C-reactive protein (CRP) levels—a marker of inflammation— it was found that the increase in CRP was lower in women supplementing with SDG compared to the placebo group.